• 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • MitoPY1 br Limitations and future research br In depth inter


    5.1. Limitations and future research
    In-depth interviews with 70 women between 19 and 78 years old provided a unique opportunity to understand women's perceptions of cervical cancer prevention, including HPV vaccination. Although 11 participants (16.4%) identified as immigrants, future reproductive justice research should focus on immigrant populations to better un-derstand issues of access to health care (Macleod et al., 2017, 2018). Although the majority of our sample reported at least some higher education, extant research suggests that HPV vaccine completion rates do not differ significantly based on level of education (Suryadevara et al., 2016). This study provides an intersectional, reproductive justice framework for future research to improve understandings of other health behaviors and disparities.
    Findings map the social, economic, and environmental axes of in-equality by multiple dimensions, including race/ethnicity, SEP, ability, age, gender, sexual orientation, and immigration status (See Fig. 1). Results identify social constructions that form women's identities, creating opportunities to intervene and implement subversive strategies to empower women to take control of their health through informed, value-based decision-making (Butler, 2010). Findings from this study provide practical implications for a reproductive justice approach to increase women's agency in the development of successful public health interventions and communication campaigns to address cervical cancer prevention, including HPV vaccination.  Social Science & Medicine 232 (2019) 289–297
    The authors would like to thank members of the Women’s Health Research Team at the College of Charleston, MitoPY1 and the Medical University of South Carolina’s Department of Public Health Sciences for their support in data collection and MitoPY1 and overall collaboration on the project. This research was supported in part by the College of Charleston’s Faculty Research and Development Grant and Office of Undergraduate Research and Creative Activities.
    Aengst, J., Layne, L.L., 2014. The need to bleed? A feminist technology assessment of menstrual-suppressing birth control pills. In: Wyer, M., Barbercheck, M., Cookmeyer, D., Ozturk, H., Wayne, M. (Eds.), Women, Science, and Technology: A Reader in Feminist Science Studies. Routledge, New York, NY, pp. 171–192.
    Agenor, M., Krieger, N., Austin, S.B., Haneuse, S., Gottlieb, B.R., 2014. At the intersection of sexual orientation, race/ethnicity, and cervical cancer screening: assessing Pap test use disparities by sex of sexual partners among black, Latina, and white U.S. women. Soc. Sci. Med. 116, 110–118.
    Arnheim-Dahlström, L., Pasternak, B., Svanström, H., Sparén, P., Hviid, A., 2013. Autoimmune, neurological, and venous thromboembolic adverse events after im-munisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 347, f5906. f5906.
    Berg, B.L., Lune, H., 2012. Qualitative Research Methods for the Social Sciences. Pearson, Boston.
    Berger, M.T., Guidroz, K., 2010. The Intersectional Approach: Transforming the Academy through Race, Class, and Gender. Univ of North Carolina Press.
    Bird, Chloe, Rieker, Patricia, 2008. The Effects of Constrained Choices and Social Practices.
    Routledge, New York.
    Cates, J., Coyne-Beasley, T., 2015. Social marketing to promote HPV vaccination in pre-teenage children: talk about a sexually transmitted infection. Hum. Vaccines Immunother. 11 (2), 347–349. CDC, 2016a. CDC Recommends Only Two HPV Shots for Younger Adolescents: Fewer Shots Offer More Incentive to Prevent HPV Cancers. Centers for Disease Control and Prevention (CDC), Atlanta, GA Retrieved from. releases/2016/p1020-hpv-shots.html.
    CDC, 2016b. HPV Vacine Coverage (Morbidity and Mortality Weekly Report). CDC Retrieved from.